Identifying Outcomes of Patients With Advanced Pancreatic Adenocarcinoma and RECIST Stable Disease Using Radiomics Analysis

Few studies have explored the biomarkers for predicting the heterogeneous outcomes of patients with advanced pancreatic adenocarcinoma showing stable disease (SD) on the initial postchemotherapy computed tomography. We aimed to devise a radiomics signature (RS) to predict these outcomes for further...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Qiuxia, Mao, Yize, Xie, Hui, Qin, Tao, Mai, Zhijun, Cai, Qian, Wen, Hailin, Li, Yong, Zhang, Rong, Liu, Lizhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966975/
https://www.ncbi.nlm.nih.gov/pubmed/35319966
http://dx.doi.org/10.1200/PO.21.00362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966975/
https://www.ncbi.nlm.nih.gov/pubmed/35319966
http://dx.doi.org/10.1200/PO.21.00362

Ejemplares similares